Bacterial interference in upper respiratory tract infections: A systematic review

被引:12
|
作者
Benninger, Michael [2 ]
Brook, Itzhak [3 ]
Bernstein, Joel M. [4 ,5 ,6 ]
Casey, Janet R. [7 ]
Roos, Kristian [8 ]
Marple, Bradley [9 ]
Farrar, Judith R. [1 ]
机构
[1] Life Sci Press, Canandaigua, NY 14424 USA
[2] Cleveland Clin, Head & Neck Inst, Cleveland, OH 44106 USA
[3] Georgetown Univ, Dept Pediat, Washington, DC 20057 USA
[4] SUNY Buffalo, Sch Med & Biomed Sci, Dept Otolaryngol, Div Infect Dis, Buffalo, NY 14260 USA
[5] SUNY Buffalo, Sch Med & Biomed Sci, Dept Pediat, Buffalo, NY 14260 USA
[6] SUNY Buffalo, Dept Commun Disorders & Sci, Buffalo, NY 14260 USA
[7] Univ Rochester, Rochester, NY USA
[8] Lundby Hosp, Dept Ear Nose & Throat, Gothenburg, Sweden
[9] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
关键词
ALPHA-HEMOLYTIC STREPTOCOCCI; MEDIA-PRONE CHILDREN; ACUTE OTITIS-MEDIA; NONTYPABLE HAEMOPHILUS-INFLUENZAE; LACTAMASE-PRODUCING BACTERIA; ADENOID ORGAN-CULTURE; STAPHYLOCOCCUS-AUREUS; CHRONIC RHINOSINUSITIS; ANTIMICROBIAL THERAPY; AMOXICILLIN-CLAVULANATE;
D O I
10.2500/ajra.2011.25.3594
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background: Published definitions of bacterial interference (BI) differ, some focusing on changes in the normal flora and others on changes in subsequent infection. A need for consensus was identified at a roundtable discussion of BI in upper respiratory tract infections (URTI). We conducted a systematic review of the available data to justify a consensus definition of BI specific to URTI as "a dynamic, antagonistic interaction between at least 2 organisms that affects the life cycle of each, changes the microenvironment, and alters the organisms' colonization, invasiveness, and ability to affect the health of the host." Methods: Continued communication among the faculty post roundtable was used to identify and refine the search criteria to (1) in vitro and in vivo studies assessing bacterial URTI, (2) BI evaluated by response to treatment of URTI with antimicrobial agents, and (3) bacterial function in relation to interactions between normal (nonpathogenic) and pathological flora. The criteria were applied to systematic searches of MEDLINE (1950 onward), EMBASE (1974 onward), and the Cochrane Library (2007). Results: Twenty-nine studies met the inclusion criteria, most focused on children with recurrent infections. Qualitative analysis supports the consensus definition. Interfering organisms affected the life cycle of test pathogens and inhibited their colonization, invasiveness, and health outcomes. Data were insufficient for statistical analysis. Conclusion: Interactions between interfering organisms and potential pathogens isolated from the same host can alter response to infection and treatment. More studies are needed, particularly in adults, to understand the role of interfering organisms, the influence of antibiotics, and the potential for recolonization posttreatment. (Am J Rhinol Allergy 25, 82-88, 2011; doi: 10.2500/ajra.2011.25.3594)
引用
收藏
页码:82 / 88
页数:7
相关论文
共 50 条
  • [41] The false dichotomy of viral versus bacterial aetiology in upper respiratory tract infections
    Davis, Joshua S.
    Magin, Parker J.
    van Driel, Mieke L.
    MEDICAL JOURNAL OF AUSTRALIA, 2019, 211 (03) : 108 - +
  • [42] TREATMENT FOR UPPER RESPIRATORY-TRACT BACTERIAL-INFECTIONS OF INFANTS AND TODDLERS
    BENAMOU, Y
    GAZETTE MEDICALE, 1987, 94 (04): : 86 - 87
  • [43] Upper respiratory tract infections -: Introduction
    Passali, D.
    JOURNAL OF CHEMOTHERAPY, 2006, 18 : 53 - +
  • [44] Prevention of Infections of the Upper Respiratory Tract
    Voss, Sebastian
    Schnakenberg, Rieke
    Weckbecker, Klaus
    Bleckwenn, Markus
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2017, 142 (03) : 217 - 224
  • [45] Efficacy of Aminomethyl Spectinomycins against Complex Upper Respiratory Tract Bacterial Infections
    Iverson, Amy
    Meyer, Christopher J.
    Vogel, Peter
    Waidyarachchi, Samanthi
    Das, Nisha
    Bruhn, David F.
    Poole, Aaron
    Butler, Michelle M.
    Bowlin, Terry L.
    Lee, Richard E.
    Rosch, Jason W.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (05)
  • [46] Antibiotic susceptibility patterns of bacterial isolates of patients with upper respiratory tract infections
    Ullah, Kalim
    Baloch, Marvi
    Saleem, Fahad
    Khan, Ayaz Ali
    Saeed, Hamid
    Islam, Muhammad
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 58
  • [47] Bacterial upper respiratory tract infections in Brazil: bacterial resistance, human resistance, scientific darkness
    Piltcher, Otavio Bejzman
    Lubianca Neto, Jose Faibes
    BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY, 2021, 87 (02) : 123 - 124
  • [48] AZITHROMYCIN OBSERVATIONAL STUDY IN BACTERIAL UPPER RESPIRATORY TRACT INFECTIONS IN INDIAN PATIENTS
    Kochhar, P.
    Donde, S.
    VALUE IN HEALTH, 2010, 13 (07) : A551 - A551
  • [49] Ribavirin for Upper Respiratory Tract Infections
    Robinson, Joan L.
    JOURNAL OF INFECTIOUS DISEASES, 2013, 208 (05): : 864 - 864
  • [50] UPPER RESPIRATORY-TRACT INFECTIONS
    RABINOWITZ, HK
    PRIMARY CARE, 1990, 17 (04): : 793 - 809